Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · July 30, 2015

Aromatase Inhibitors Improve Survival and Reduce Recurrence in Early Breast Cancer

The Lancet

 

Additional Info

The Lancet
Aromatase Inhibitors Versus Tamoxifen in Early Breast Cancer: Patient-Level Meta-Analysis of the Randomised Trials
Lancet 2015 Jul 23;[EPub Ahead of Print], Early Breast Cancer Trialists' Collaborative Group (EBCTCG)

Further Reading